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Summary.-The growth characteristics of 6 human colorectal tumours have been
examined during serial passage in both male and female immune-deprived mice.
Exponential growth is a characteristic feature, especially on very early passages.
Growth rates in 5 out of the 6 tumour lines increase during the first few transplant
generations. This is accompanied by a shorter exponential growth phase and an
increased slope of the growth curves. Lag phases and growth rates for individual
tumours are variable within a passage. Growth rates for tumours maintained within
the same host are similar, and are at least partially influenced by the host. In one
tumour line examined in detail, the increased growth rate is attributable to a de-
creased cell-loss factor, and the difference in growth rate between human colorectal
tumours and their corresponding xenografts may therefore largely be due to a
difference in the contribution of this factor.
ANIMAL tumours used for screening
procedures in the selection of cytotoxic
agents with potential clinical application
are in general rapidly growing, and often
have high growth fractions, whereas
clinically many of the more common solid
tumours appear to be relatively slow
growing, probably with growth fractions
considerably less than those found in
rodent tumours. It is hoped that the
human xenograft tumour may provide a
practical experimental model which will
simulate the human disease to a greater
degree in its cellular proliferation kinetics.
There is therefore a need for more data
on the growth patterns of human primary
tumours growing in immune-deprived
mice, to establish whether the xenograft
retains the growth characteristics ob-
served in the clinic, and to assess whether
these characteristics are maintained during
serial passage. Six human colorectal tu-
mour xenografts have been established in
immune-deprived mice, and their growth
characteristics studied for up to 10 trans-
plant generations.
MATERIALS AND METHODS
Immune deprivation of mice.-Four-week-
old male and female CBA/lac mice were
immune-deprived as previously described
(Houghton, Houghton and Taylor, 1977).
Tumour implantation.-Tumour tissue was
obtained at operation and implants were
completed within 6 h of removal from the
patient. Tissue was placed in ice-cold Medium
199 containing benzyl penicillin sodium
(200 u/ml) and streptomycin sulphate (100
,ug/ml) and transported to the laboratory on
ice. Potentially viable sections were dissected
from the invading tumour margin for im-
plantation. Pieces 8 mm3 were cut and
bilateral implants made s.c. into the flanks of
each of 20 male and 20 female immune-
deprived mice. Due to the possibility of
bacterial contamination fromthesespecimens,
the mice were each injected i.p. with 75 mg/kg
penicillin and 25 mg/kg streptomycin 30 min
before tumour implantation. This time was
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considered sufficient to achieve high anti-
biotic blood levels. On Passage 1 no animals
subsequently died from gross bacterial infec-
tion induced by tumour inoculation. Pas-
sagedtumours wereseriallytransplanted upon
reaching a diameter of 2 cm, tumour pieces
from male and female mice being retrans-
planted bilaterally into hosts ofthe same sex.
For the percentage-labelled-mitoses tech-
nique, 4 tumour implants were made per
mouse, 2 specimens being implanted into each
flank.
Estimation of tumour volume.-Two per-
pendicular diameters wAere measured for each
tumour at wAeekly intervals, using vernier
calipers. Estimations of tumour volume wNere
made by substitution in the formula -r/6 X d3,
where d is the mean tumour diameter
(Kopper and Steel, 1975).
Analysis of cell kinetic parameters.-The
technique of labelled mitoses was used. Mice
each bearing 4 tumours of less than 1 cm
diameter were injected i.p. with 25 ,uCi
6-3H-thymidine (sp. act. 27 Ci/mmol; Radio-
chemical Centre, Amersham). Whole tumours
were excised at various times for up to 72 h
after injection, the two tumours from one
flank being removed at any one time. Tumours
were fixed in formol saline and autoradio-
graphs were prepared according to the
method of Pickard, Cobb and Steel (1975).
Mitotic and labelling indices were estimated
by counting the cells from 50 microscope
fields (- 5500 cells) using the first tumour
from each series (either at 1 or 2 h). At least
75 metaphase or anaphase figures wNere
scored in the estimation of the fraction of
labelled mitoses. Background labelling was
estimated as 2 grains/cell.
Analysis of the data was performed by the
optimizing computer program described by
Steel and Hanes (1971).
Cell-loss factor and growNth fraction were
calculated by the method of Steel (1968).
Tumour lines. The 6 human colorectal
tumour xenograft lines, maintained in both
male and female immune-deprived CBA/lac
mice, have been described previously (Hough-
ton and Taylor, 1977). BrieflY, they comprise
the following:
HXBR- moderately well-differentiated
adenocarcinoma of the rectum,
maintained for 5 passages in both
male and female mice:
HXAC4- moderately well-differentiated
adenocarcinoma of the caecum,
maintained for 4 passages in male
hosts only;
HXHC1- moderately well-differentiated
adenocarcinoma from the ascend-
ing colon, studied for 10 serial
passages in female mice only;
HXGC3 poorly differentiated adenocarci-
noma from the transverse colon,
maintained for the first 10
passages in both male and female
hosts;
HXVRC5 poorly differentiated adenocarci-
noma of the caecum, maintained
for 8 passages in male hosts and
for 10 passages in female mice;
and
HXELC2 poorly differentiated carcinoma of
the caecum, studied for 10 serial
passages in both host sexes.
Since they all carry the initial letters HX,
for the sake of clarity these letters will be
omitted from further references to the
tumour lines.
RESUILTS
Tumour growth rates
Growth curves were constructed on
semi-log graph paper, and the curves
fitted to the data points by eye. In each
tumour line, there were wide variations
in growth rate on Passage 1 for tumours
maintained in both male and female
mice. For serial passaging, tumours selec-
ted for transplantation were chosen care-
fully, to encompass tumours with widely
differing growth rates. However, in spite
of a careful selection, the tumours trans-
planted, whether fast- or slow-growing
within a particular passage, continued to
produce tumours in the subsequent pas-
sage with wide variations in growth rate.
Different lag times in the appearance of
palpable tumours were also evident within
a passage. In each of the 6 tumour lines
studied, a growth pattern which approxi-
mated to an exponential volume increase
was evident for the initial growth period,
followed by a slowing of growth rate. In 5
of the 6 tumour lines (all except ELC2)
growth rates increased upon serial passage,
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FIe. 1. Growth curves for soine ttumouirs in Passages 1 an(i 5 in Ttumotur Line BR maintainie(d in male mice. Each curve represenrts the? growth of a single tumouir. An increase in growxth rate is observed betwNeen Passages I an(d 5.
and this was accompanied by a shorter
exponential growth phase and an increased
slope of the growth curves. This is illus-
trated in Fig. 1, which shows the fitting
of growth curves to the data points in the
moderately well-differentiated Tumour
Line BR in male hosts, for tumours on
Passages 1 and 5. Due to the often
large numbers of tumours within any one
passage, data have not been shown for
each tumour, although those displayed
are considered representative. Each curve
demonstrates thegrowthofa singletumour
In the Passage I tumour of this tumour
line, a marked exponential growth phase
was apparent, and by Passage 5 there
was an increase in growth rate accom-
panied by a slightly shorter period of
exponential growth in some tumours.
Similar observations were made with BR
tumours maintained in female host mice.
Fig. 2 shows tumours on Passage 1 and 8
of Tumour Line ELC2 (poorly differen-
tiated) in male hosts. Exponential growth
was evident, and tumours of this series
demonstrated no increase in growth rate
with serial passage. Similar results were
obtained with ELC2 tumours maintained
as a line in female mice, except in Passage
1, in which tumours grew more slowly.
Growth curves in some tumours assumed
an irregular growith pattern.
Tiumour-volume doubling times
These were calculated when tumours
hiadreached avolume of0 4 cm3 (-, 9-3 mm
diameter) by which time s.c. growing
tumours had become established. Estima-
tion of volume-doubling times for indi-
vidual tumours using this method enables
the calculation of the range of tumour
growth rates within any one passage. The
number of passages required for a signifi-
cant increase in growth rate to occur over
that measured in Passage 1 was also
calculated in each tumour line. Fig. 3
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FIG. 2. Growth curves fitte(d to (lata points for some tumours of ELC2 maintained in male mice in
Passages 1 and 8. No increase in growth rate occurred.
shows the volume-doubling times of indi-
vidual tumours at 04 cm3 plotted against
the passage number for Tumour Line BR.
It is apparent that within each tumour
line and in both male and female mice a
wide variation in growth rate occurred
within any one passage. This was also
true of the 5 remaining tumour lines (AC4,
HC1, CC3, VRC5 and ELC2). Tumours
arising as "single takes" within a host,
where only one tumour evolved from
bilateral implantations, were seen to occur
at either the fast or slow growing ends
of the spectrum within any one passage.
Growth rates increased in all tumour
lines (except ELC2) whether tumours
were maintained in male or female hosts.
In Fig. 4, the mean volume-doubling times
and standard deviations for all tumour
lines and each passage in both male and
female mice are presented. Growth rates
generally increased during the first few
transplant generations.
Inftuence of the host
Correlation of tumour growth rates within
the same host. From the data already
presented, at 04 cm3 volume a wide
variation in the growth rates of tumours
occurred within any one passage. Where
bilateral tumours grew, it was possible to
analyse data within a tumour line to
ascertain the possibility of fast- and slow-
growing tumours occurring within the
same host, or alternatively in different
host mice. Using the tumour-volume
doubling times at 04 cm3, already shown,
the value for the faster growing of the
2 tumours within any one host was
plotted on the abscissa, and the value for
the more slowly growing tumour on the
ordinate. Results for Tumour Line ELC2
are shown in Fig. 5, where different sym-
bols represent different passage numbers.
Regression lines and significance were
calculated (Student's t test, P<O0O5), for
both host sexes. In all tumour lines,
Passage 8
'u
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FIG. 3. Volume-doubling times of individual
ttumours at 0-4 cm3 in Tumour Line BR
are plottedl for each passage in both male
and female mice. Symbols 0 an(d 0 repre-
senit the growth of tumours occutrring as
siingle or double takes respectively within
mice, from bilateral implants.
whether maintained in male or female
hosts, the correlation between growth
rates of tumours maintained within the
same host was significant. This suggests,
therefore, that within any one passage
either only fast- or only slow-growing
tumours occurred in the same host animal.
For each passage and tumour line, an
analysis of variance on groups of two
tumours maintained within the same host
showed that in each passage there was
always a greater variation of growth rates
between mice than within the same mouse.
Assessment of 0, 1 or 2 tumour takes per
hostfrom bilateral imiplants. Results from
this analysis are presented in Table I for
each tumour line and passage. The
numbers and percentages of single takes
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FIG. 4. Mean volume-doubling times for
tumours at 0-4 cm3 are plotted against the
passage number for each tumour line and
host sex (mean + s.d.). Solid lines indicate
a significant decrease in tumour-volume
doubling times from Passage 1 (P<0-05).
Growth rates apparently increase signifi-
cantly during the first few transplant
generations in all tumour lines except
ELC2, and VRC5 in female mice.
decreased significantly during serial pas-
sage. Results from passaged tumours were
found to differ significantly from those
predicted from the binomial distribution,
when predicted and observed values were
subjected to ax2 analysis. Observed values
for Passage 1 tumours in each tumour line
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FIG. 5. The similarity of tumour-volume doubling times (Td2) for tumours growing within the same
host is significant using Student's t test (P<005). Tumour Line ELC2 is shown. Within any one
host, the value for the faster growing turnour is plotted on the abscissa, and the value for the more
slowly growing tumour on the ordinate. Symbols are * P1, 0 P2, * P3, A P4, * P5, [ P6,
V P7, 7 P8, + P9, x P1O.
except VRC5 maintained in female mice
appeared to correlate with predicted
values. All other passages demonstrated
a significant difference (P<0 05) between
these two parameters. Mice therefore
appeared to maintain the growth of
either 2 or 0 tumours from bilateral
implants. Take rates were in general
higher in male than in female mice for
early passages, although similar takes
were seen in both host sexes by Passage 8.
Cell-proliferation kinetics
The percentage-labelled-mitoses tech-
nique (PLM) was applied to GC3 tumours
on Passages 3 and 10 in male mice.
Tumour Line GC3 was selected for study,
as the mean volume-doubling time cal-
culated at 0 4 cm3 decreased from 11.1
to 6-6 days between Passages 3 and 10,
and unless growth rates almost double
between the passages selected for study,
it is difficult to obtain from the PLM
technique an indication of the nature of
the observed changes (Dr G. G. Steel,
personal communication). Frozen tumour
pieces of GC3 (previously stored in liquid
N2) at Passage 1 were thawed and trans-
planted to give sufficient Passage 2
tumour material for an analysis to be
made on Passage 3. The computed PLM
curves, obtained by the method of Steel
and Hanes (1971) are shown in Fig. 6.
The curves for the two passages are
similar. In both cases, the first peaks are
well defined, although the second peaks
fall well below the 50%0 level, suggesting
wide variations in intermitotic times for
both passages. The distribution of inter-
mitotic times calculated using the compu-
ter model is shown in Fig. 7. Broad
distributions are apparent, but the spread
is similar for both the early and the later-
passage tumours. The computed cell-cycle
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the errors of the technique, the growth
fraction would appear to remain fairly
constantduringserialpassage. Thegreatest
change is apparently in the cell-loss
factor. The relative contributions that
these two parameters may make toward
the observed increase in growth rate in
this tumour line can be estimated from
the formula:
Td
Tc
loge2
(1-- 0)loge(GF + 1)
where Td is the actual volume-doubling curves for Tumour Line GC3
3 ancl 10 in male hosts (lemon- time, Tc the cell-cycle time, 0 the cell-loss rcell-cycle parameters. factor, and GF the growth fraction (Dr
G. G. Steel, personal communication). By
maintaining U±i' constant at 65% (tne
value obtained for Passage 3 tumours) and
substituting the calculated cell-loss factor
for Passage 3 (86%) and Passage 10 (76%)
in the equation, the ratio Td/Tc decreases
from 3-0 to 1-75. Alternatively, by keeping
the cell-loss factor constant at 86%, and
substituting the calculated growth frac-
tions for Passage 3 (65%) and Passage 10
(69%) in the equation, the ratio Td/Tc
decreases only marginally from 3 0 to
0 2*93. As Tc is constant between Passages
3 and 10, a 100% decrease in cell loss appears
ermitotic time(h) to have a substantial effect on the ob-
ilar but broad (distribution of served volume-doubling time, sufficient
times, calculated using the to account for the degree of change
odel of Steel andl Hanes (1971), obtained.
is observedl in Passages 3 ain(l 10 ofTumou-
Line GC3 maintaine(d in male hosts.
parameters are shown in Table II. A
decrease in cell-cycle time does not
apparently account for the observed
increase in growth rate in Tumour Line
GC3, as the median intermitotic times and
constituent phase durations (G1, G2) are
similar for both passages.
The mitotic and labelling indices in
this series of tumours were similar to the
results obtained by Pickard et al. (1975)
on another series of human colorectal
tumour xenografts. The growth fractions
in Passages 3 and 10 of GC3 were 65 and
69% respectively, and the corresponding
cell-loss factors were 86 and 76%. Within
DISCUSSION
Clinically, the growth rates of human
colorectal tumours are often slow, volume-
doubling times being estimated between
138 and 1155 days (Welin et al., 1963).
Terz, Curutchet and Lawrence (1971) in-
vestigated recurrent rectal carcinoma and
found the mean values for Tc, G2 and S to
be 26, 5-7 and 14 h respectively, very
similar results to those for normal human
transverse colon and rectum reported by
Lipkin, Bell and Sherlock (1963).
Pickard et al. (1975) suggested that the
cell kinetic parameters for first-passage
human colorectal tumour xenografts were
similar to those measured in patients, but
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found no appreciable period of exponen-
tial growth in the xenografts. Lamerton
and Steel (1975) concluded that the
growth rates of these xenografts did not
increase to any extent during serial
passage, but were much higher than for
human colorectal tumours in patients, a
fact attributable to a difference in cell
loss.
In the current study, a significant
increase in growth rate occurred in 5
of the 6 tumour lines in both male and
female mice, usually within the initial few
transplant generations. Within any one
passage, the growth of individual tumour
lines was characterized by variability in
growth rate and lag time, but individual
tumours demonstrated a marked period of
exponential growth. Only limited data are
available concerning the growth pattern
of human tumours within patients, al-
though many human lung tumours have
been found to grow approximately expo-
nentially (Steel and Lamerton, 1966).
Evidence has been presented that
individual host mice at least partially
influence the growth of implanted tumour
pieces, and the rate of growth of estab-
lished tumours. Within any one passage
the growth rates of tumours maintained
within the same host were similar, and this
correlation was significant in each tumour
line. It is possible that the extent of host
influence on tumour growth rates may
depend upon the extent of individual host
immune-deprivation, which may in turn
influence the rate of cell loss within a
tumour. In addition, the numbers of
single tumour takes decreased significantly
upon passaging, and after Passage 1 in
each tumour line the observed values
differed significantly from those predicted
from the binomial distribution. It is
possible that the higher incidence of
single takes on Passage 1 may be due to the
balance between the ability of the im-
planted human tumour piece to withstand
the initial period of hypoxic ischaemia
until the tumour vasculature becomes
established, and the effect of host residual
immunity on the introduction of foreign
material. It is probable that further trans-
plants from an established tumour are able
to survive this initial period of hypoxia
(selection) and in these circumstances host
defences may then be more important in
the determination of tumour takes within
individual host mice.
Irregular growth patterns were observed
in some instances where the tumour
growth rate decreased for a period of time
before returning to a more rapid rate.
Similarobservations were madebyPickard
et al. (1975) who also noted the occur-
rence of spontaneous regressions. The
reason for such irregularities is not clear,
although they should be considered espe-
cially during chemotherapeutic trials, and
where growth delay is used as the sole
criterion for assessment of drug efficacy.
In one tumour line studied in detail,
namely GC3 maintained in male hosts, the
increase in growth rate observed could be
accounted for by a 10% decrease in the
cell-loss factor between Passages 3 and 10.
This appeared to occur without concomi-
tant influence from a change in cell-cycle
time, or growth fraction where the slight
increase obtained was insufficient to
account for the degree of change observed.
It would seem unlikely, therefore, that
selection of the fastest-growing cells had
taken place. The possible cause for the
decrease in cell loss during serial passage
is not clear. A progressive decrease in
tumour antigenicity may be responsible
where there may be selection of the least
antigenic cells or progressive coating of
surface antigens by antibody, thus allow-
ing less antigen to be exposed (Rees and
Westwood, 1974).
Results suggest that the cell-loss factor
may in fact be the major kinetic change
observed during serial passage, and this
appears not to affect the chemosensitivity
(Houghton and Houghton, unpublished).
It has been reported previously that this
series of human colorectal tumour xeno-
grafts appears to maintain the histological,
mucin-secreting and CEA-producing
characteristics ofthe corresponding human
primary tumours, in addition to the
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maintenance of human lactate dehydro-
genase and glucose-6-phosphate dehydro-
genase isoenzyme patterns and a human
chromosome constitution (Houghton,
1977; Houghton and Taylor, 1977). Evi-
dence to date suggests that even with
continued serial passage over 2 to 3 years,
these xenografts maintained in immune-
deprived mice appear not to change
appreciably from the primary human
specimen.
We would like to thank Dr G. G. Steel and Dr N.
M. Blackett for very helpful discussions during this
analysis, and Miss S. Clinton for preparation of the
autoradiographs.
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